Cargando…
Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336090/ https://www.ncbi.nlm.nih.gov/pubmed/36068567 http://dx.doi.org/10.1186/s12943-022-01614-9 |
| _version_ | 1784759470335721472 |
|---|---|
| author | Li, Heng Yu, Gan Shi, Runlin Lang, Bin Chen, Xianguo Xia, Ding Xiao, Haibing Guo, Xiaolin Guan, Wei Ye, Zhangqun Xiao, Wei Xu, Hua |
| author_facet | Li, Heng Yu, Gan Shi, Runlin Lang, Bin Chen, Xianguo Xia, Ding Xiao, Haibing Guo, Xiaolin Guan, Wei Ye, Zhangqun Xiao, Wei Xu, Hua |
| author_sort | Li, Heng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9336090 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93360902022-07-30 Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy Li, Heng Yu, Gan Shi, Runlin Lang, Bin Chen, Xianguo Xia, Ding Xiao, Haibing Guo, Xiaolin Guan, Wei Ye, Zhangqun Xiao, Wei Xu, Hua Mol Cancer Correction BioMed Central 2022-07-28 /pmc/articles/PMC9336090/ /pubmed/36068567 http://dx.doi.org/10.1186/s12943-022-01614-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Li, Heng Yu, Gan Shi, Runlin Lang, Bin Chen, Xianguo Xia, Ding Xiao, Haibing Guo, Xiaolin Guan, Wei Ye, Zhangqun Xiao, Wei Xu, Hua Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy |
| title | Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy |
| title_full | Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy |
| title_fullStr | Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy |
| title_full_unstemmed | Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy |
| title_short | Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy |
| title_sort | correction: cisplatin-induced epigenetic activation of mir-34a sensitizes bladder cancer cells to chemotherapy |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336090/ https://www.ncbi.nlm.nih.gov/pubmed/36068567 http://dx.doi.org/10.1186/s12943-022-01614-9 |
| work_keys_str_mv | AT liheng correctioncisplatininducedepigeneticactivationofmir34asensitizesbladdercancercellstochemotherapy AT yugan correctioncisplatininducedepigeneticactivationofmir34asensitizesbladdercancercellstochemotherapy AT shirunlin correctioncisplatininducedepigeneticactivationofmir34asensitizesbladdercancercellstochemotherapy AT langbin correctioncisplatininducedepigeneticactivationofmir34asensitizesbladdercancercellstochemotherapy AT chenxianguo correctioncisplatininducedepigeneticactivationofmir34asensitizesbladdercancercellstochemotherapy AT xiading correctioncisplatininducedepigeneticactivationofmir34asensitizesbladdercancercellstochemotherapy AT xiaohaibing correctioncisplatininducedepigeneticactivationofmir34asensitizesbladdercancercellstochemotherapy AT guoxiaolin correctioncisplatininducedepigeneticactivationofmir34asensitizesbladdercancercellstochemotherapy AT guanwei correctioncisplatininducedepigeneticactivationofmir34asensitizesbladdercancercellstochemotherapy AT yezhangqun correctioncisplatininducedepigeneticactivationofmir34asensitizesbladdercancercellstochemotherapy AT xiaowei correctioncisplatininducedepigeneticactivationofmir34asensitizesbladdercancercellstochemotherapy AT xuhua correctioncisplatininducedepigeneticactivationofmir34asensitizesbladdercancercellstochemotherapy |